Ascent Partners is proud to have provided ESG Strategy advice for Lepu Scientific on their recent IPO
Ascent Partners was delighted to work with Lepu Scientech Medical Technology (Shanghai) Co., Ltd. (HK2291) on their recent IPO in Hong Kong Lepu Scientech Medical Technology (Shanghai) Co., Ltd. is an independent subsidiary